Innovative Medical Technology Kardium has developed the Globe System, a groundbreaking device for atrial fibrillation diagnosis and treatment, indicating a strong position in the advanced medical device market for cardiac health.

Strong Market Entry Recent launch of the Globe Pulsed Field System following FDA approval and successful commercialization suggests ongoing growth opportunities and expanding market presence in the US.

Robust Funding & Revenue With over 250 million dollars in recent funding and a revenue range of 50 to 100 million dollars, Kardium demonstrates solid financial health, making it a promising partner for investment and procurement opportunities.

Strategic Collaborations Kardium’s investments into biomedical startups such as Corline Biomedical and its active participation in research studies like PULSAR indicate potential for collaborative ventures and early adoption in emerging therapies.

Recognized Employer & Innovator Being recognized as a top employer in BC highlights a strong company culture and talent pool, positioning Kardium as a reliable supplier with skilled personnel to support ongoing sales and service efforts.